CATALAYER NEWS
FDA grants fast track status to Aclaris’ lichen planus drug
Source: Investing.com · 2026-08-06
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Earnings call transcript: Relmada posts Q2 2026 EPS beat as shares slip
2026-08-06
MP Materials misses earnings despite revenue beat
2026-08-06
Earnings call transcript: TriSalus tops Q2 revenue forecast, stock slips after hours
2026-08-06
Earnings call transcript: Ardelyx cuts guidance as stock sinks in Q2 2026
2026-08-06
Pulse Biosciences enters $75 million equity distribution agreement with Mizuho
2026-08-06
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets